TSOI Stock Overview
Therapeutic Solutions International, Inc. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Therapeutic Solutions International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0004 |
| 52 Week High | US$0.0013 |
| 52 Week Low | US$0.0001 |
| Beta | 1.52 |
| 1 Month Change | 33.33% |
| 3 Month Change | -42.86% |
| 1 Year Change | -55.56% |
| 3 Year Change | -98.12% |
| 5 Year Change | -80.95% |
| Change since IPO | -99.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| TSOI | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 33.3% | 3.7% | -2.2% |
| 1Y | -55.6% | -0.7% | 18.3% |
Return vs Industry: TSOI underperformed the US Pharmaceuticals industry which returned -0.7% over the past year.
Return vs Market: TSOI underperformed the US Market which returned 18.3% over the past year.
Price Volatility
| TSOI volatility | |
|---|---|
| TSOI Average Weekly Movement | 57.9% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 17.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: TSOI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: TSOI's weekly volatility has increased from 36% to 58% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 3 | Tim Dixon | www.therapeuticsolutionsint.com |
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.
Therapeutic Solutions International, Inc. Fundamentals Summary
| TSOI fundamental statistics | |
|---|---|
| Market cap | US$2.05m |
| Earnings (TTM) | -US$2.41m |
| Revenue (TTM) | US$85.32k |
24.0x
P/S Ratio-0.9x
P/E RatioIs TSOI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSOI income statement (TTM) | |
|---|---|
| Revenue | US$85.32k |
| Cost of Revenue | US$29.18k |
| Gross Profit | US$56.14k |
| Other Expenses | US$2.47m |
| Earnings | -US$2.41m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00047 |
| Gross Margin | 65.80% |
| Net Profit Margin | -2,824.94% |
| Debt/Equity Ratio | 49.0% |
How did TSOI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 21:24 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Therapeutic Solutions International, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.